ModivCare

Medicare Reimbursement Cuts And Digital Rivals Will Weaken Revenues

AnalystLowTarget

Not Invested

Community Contributor

Published

14 Aug 25

n/a

AnalystLowTarget's Fair Value

n/a

-100.0%

29.0%

-100.0%

29.0%

You can edit this narrative until Aug 14 10:20 PM. Then, changes will post as Updates.

Author's Valuation

US$1.299.7% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$1.2

99.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

0.00%

Healthcare Services revenue growth rate

0.22%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.50%

Calculation

US$159.74m

Earnings '28

0.16x

PE Ratio '28

US$25.00m

Market Cap '28

US$25.00m

Market Cap '28

14.70m

No. shares '28

US$1.70

Share Price '28

US$1.70 Share Price '28

Discounted to 2025 @ 12.32% p.a.

US$1.20

Fair Value '25